Flossbach Von Storch’s Gilead Sciences GILD Stock Holding History

Flossbach Von Storch’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,930	Closed	-$219K	–	101
2020 Q1	$219K	Buy	+2,930	New	+$202K	﹤0.01%	104
2018 Q3	–	Sell	-3,770	Closed	-$267K	–	116
2018 Q2	$267K	Hold	3,770	–	–	﹤0.01%	101
2018 Q1	$284K	Hold	3,770	–	–	﹤0.01%	98
2017 Q4	$270K	Buy	3,770 +150	+4%	+$11.4K	﹤0.01%	98
2017 Q3	$293K	Hold	3,620	–	–	﹤0.01%	97
2017 Q2	$256K	Buy	3,620 +400	+12%	+$26.6K	﹤0.01%	94
2017 Q1	$219K	Hold	3,220	–	–	﹤0.01%	98
2016 Q4	$231K	Buy	+3,220	New	+$239K	﹤0.01%	98
2015 Q1	–	Sell	-3,000	Closed	-$283K	–	103
2014 Q4	$283K	Hold	3,000	–	–	0.01%	94
2014 Q3	$319K	Hold	3,000	–	–	0.01%	83
2014 Q2	$249K	Buy	+3,000	New	+$234K	0.01%	85

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Flossbach Von Storch's GILD Position: Q2 2020 in Review

Flossbach Von Storch sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 2,930 shares — an estimated $219K sold.

Flossbach Von Storch first reported a position in GILD in Q2 2014 and held it in 11 quarters. The position peaked at $319K in Q3 2014. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Flossbach Von Storch reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Flossbach Von Storch sold 2,930 Gilead Sciences shares in Q2 2020, an estimated $219K.
Flossbach Von Storch first reported a position in Gilead Sciences in Q2 2014 and held it in 11 quarters.
Flossbach Von Storch's Gilead Sciences position peaked at $319K in Q3 2014.
1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Flossbach Von Storch's 13F filing for Q2 2020, filed 10 Aug 2020.